A promising natural anthraquinones mediated by photodynamic therapy for anti-cancer therapy
Phytomedicine · 2023
DOI: 10.1016/j.phymed.2023.155035 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytomedicine, 2023. Verfasst von Martyna Nowak-Perlak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Pathology, Division of General and Experimental Pathology, Wroclaw Medical University, Karola Marcinkowskiego…. Hauptthemen laut MEDLINE: Photosensitizing Agents, Anthraquinones. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu, Ministerstwo Edukacji i Nauki.
Abstract (Originalsprache)
BACKGROUND: Experimental studies emphasize the therapeutic potential of plant-derived photosensitizers used in photodynamic therapy. Moreover, several in vitro and in vivo research present the promising roles of less-known anthraquinones that can selectively target cancer cells and eliminate them after light irradiation. This literature review summarizes the current knowledge of chosen plant-based-photosensitizers in PDT to show the results of emodin, aloe-emodin, parietin, rubiadin, hypericin, and soranjidiol in photodynamic therapy of cancer treatment and describe the comprehensive perspective of their role as natural photosensitizers. METHODS: Literature searches of chosen anthraquinones were conducted on PubMed.gov with keywords: "emodin", "aloe-emodin", "hypericin", "parietin", "rubiadin", "soranjidiol" with "cancer" and "photodynamic therapy". RESULTS: According to literature data, this review concentrated on all existing in vitro and in vivo studies of emodin, aloe-emodin, parietin, rubiadin, soranjidiol used as natural photosensitizers emphasizing their effectiveness and detailed mechanism of action in anticancer therapy. Moreover, comprehensive preclinical and clinical studies on hypericin reveal that the above-described substances may be included in the phototoxic treatment of different cancers. CONCLUSIONS: Overall, this review presented less-known anthraquinones with their promising molecular mechanisms of action. It is expected that in the future they may be used as natural PSs in cancer treatment as well as hypericin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Experimental Pathology, Division of General and Experimental Pathology, Wroclaw Medical University, Karola Marcinkowskiego 1 Street, 50-368, Wroclaw, Poland. Electronic address: martyna.nowak-…
- Department of Clinical and Experimental Pathology, Division of General and Experimental Pathology, Wroclaw Medical University, Karola Marcinkowskiego 1 Street, 50-368, Wroclaw, Poland.
Förderung
- Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu
- Ministerstwo Edukacji i Nauki
Zitieren
APA
Nowak-Perlak, M., Ziółkowski, P., & Woźniak, M. (2023). A promising natural anthraquinones mediated by photodynamic therapy for anti-cancer therapy. Phytomedicine. https://doi.org/10.1016/j.phymed.2023.155035
Vancouver
Nowak-Perlak M, Ziółkowski P, Woźniak M. A promising natural anthraquinones mediated by photodynamic therapy for anti-cancer therapy. Phytomedicine. 2023. doi:10.1016/j.phymed.2023.155035
BibTeX
@article{NowakPerlak2023,
author = {Nowak-Perlak, Martyna and Ziółkowski, Piotr and Woźniak, Marta},
title = {A promising natural anthraquinones mediated by photodynamic therapy for anti-cancer therapy},
journal = {Phytomedicine},
year = {2023},
doi = {10.1016/j.phymed.2023.155035}
}
EUVIMED